Related Experiment Video

Updated: May 12, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Use of monoclonal antibodies for preparing human immunoglobulin M-coated red blood cells

Patricia A Arndt, George Garratty

    Transfusion
    |April 10, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    Related Experiment Videos

    Last Updated: May 12, 2026

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
    13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...

    Articles linked to this work by shared authors, journal, and citation graph.

    Utility of chloroquine diphosphate in the blood bank laboratory.

    Immunohematology·2018

    Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.

    Transfusion·2017

    First example of an FY*01 allele associated with weakened expression of Fya on red blood cells.

    Immunohematology·2016

    Profound autoimmune hemolysis and Evans syndrome in two asplenic patients with babesiosis.

    Transfusion·2014

    Drug-induced immune hemolytic anemia: the last 30 years of changes.

    Immunohematology·2014

    Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007.

    Immunohematology·2014

    The transformative power of artificial intelligence and machine learning in blood banking/transfusion medicine: A vein-to-vein approach from blood collection to transfusion services: On behalf of the AABB Foundation.

    Transfusion·2026

    How do I create a cost structure for cellular therapy laboratory services supporting clinical trials?

    Transfusion·2026

    Donor age is the major determinant of low-level blood lead burden in the REDS recalled donor cohort.

    Transfusion·2026

    No difference in alloimmunization of pregnant adults with sickle cell disease exposed to chronic versus on-demand transfusions: A two-center retrospective cohort study.

    Transfusion·2026

    A distinctive RhD serologic phenotype expressed by p.Glu233Lys RHD alleles DV type 5 and DAU4 in microplate agglutination RhD typing.

    Transfusion·2026

    Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic.

    Transfusion·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us